Literature DB >> 26686323

Novel X-linked syndrome of cardiac valvulopathy, keloid scarring, and reduced joint mobility due to filamin A substitution G1576R.

Paldeep Singh Atwal1,2,3, Sophie Blease1, Alicia Braxton2, Julia Graves4, Weimin He2, Richard Person2, Leah Slattery1, Jonathan Adam Bernstein1, Louanne Hudgins1.   

Abstract

Filamin A (FLNA) is known to be involved in intracellular actin binding, cell migration, scaffolding, and signaling. We report a novel X-linked syndrome characterized by cardiac valvular disease, keloid scarring and reduced joint mobility in male second cousins due to a previously unreported mutation in FLNA. Whole exome sequencing was performed using standard methods and segregation analysis was performed in affected and non-affected family members. A novel hemizygous c.4726G>A (p.G1576R) mutation in FLNA was detected. Segregation analysis performed on multiple maternal family members showed c.4726G>A (p.G1576R) segregated with disease in an X-linked inheritance pattern. The findings in these cases are distinct from previously described FLNA related disorders by virtue of decreased joint mobility and spontaneous keloid scarring. They occur in association with a novel mutation and represent a novel genetic syndrome.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  FLNA; G1576R; cardiac valvulopathy; joint hypomobility; keloid scar

Mesh:

Substances:

Year:  2015        PMID: 26686323     DOI: 10.1002/ajmg.a.37491

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  6 in total

1.  Molecular Modeling and Phenotypic Description of a Patient with a Novel Exonic Deletion of GALNS with Resultant Morquio Syndrome with Two Successful Pregnancies.

Authors:  Pavalan Selvam; Angita Jain; Jessica Abbott; Abhimanyu S Ahuja; Anvir Cheema; Katelyn A Bruno; Herjot Atwal; Irman Forghani; Thomas Caulfield; Paldeep S Atwal
Journal:  Mol Syndromol       Date:  2022-03-09

2.  Mutations in MAP3K7 that Alter the Activity of the TAK1 Signaling Complex Cause Frontometaphyseal Dysplasia.

Authors:  Emma M Wade; Philip B Daniel; Zandra A Jenkins; Aideen McInerney-Leo; Paul Leo; Tim Morgan; Marie Claude Addor; Lesley C Adès; Debora Bertola; Axel Bohring; Erin Carter; Tae-Joon Cho; Hans-Christoph Duba; Elaine Fletcher; Chong A Kim; Deborah Krakow; Eva Morava; Teresa Neuhann; Andrea Superti-Furga; Irma Veenstra-Knol; Dagmar Wieczorek; Louise C Wilson; Raoul C M Hennekam; Andrew J Sutherland-Smith; Tim M Strom; Andrew O M Wilkie; Matthew A Brown; Emma L Duncan; David M Markie; Stephen P Robertson
Journal:  Am J Hum Genet       Date:  2016-07-15       Impact factor: 11.025

3.  Type 1 sialidosis presenting with ataxia, seizures and myoclonus with no visual involvement.

Authors:  Ahmed N Mohammad; Katelyn A Bruno; S Hines; Paldeep S Atwal
Journal:  Mol Genet Metab Rep       Date:  2018-01-12

4.  The infantile neuroaxonal dystrophy rating scale (INAD-RS).

Authors:  Paldeep S Atwal; Mark Midei; Darius Adams; Alexander Fay; Frederic Heerinckx; Peter Milner
Journal:  Orphanet J Rare Dis       Date:  2020-07-29       Impact factor: 4.123

5.  Case Report: Pansynostosis, Chiari I Malformation and Syringomyelia in a Child With Frontometaphyseal Dysplasia 1.

Authors:  Jaewon Kim; Dong-Woo Lee; Dae-Hyun Jang
Journal:  Front Pediatr       Date:  2021-07-01       Impact factor: 3.418

6.  FLNA mutations in surviving males presenting with connective tissue findings: two new case reports and review of the literature.

Authors:  Elyssa Cannaerts; Anju Shukla; Mensuda Hasanhodzic; Maaike Alaerts; Dorien Schepers; Lut Van Laer; Katta M Girisha; Iva Hojsak; Bart Loeys; Aline Verstraeten
Journal:  BMC Med Genet       Date:  2018-08-08       Impact factor: 2.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.